Afficher la notice abrégée

Clinical and pharmacological correlates of caffeine consumption in subjects with schizophrenia – Data from the FACE-SZ cohort

dc.rights.licenseopenen_US
dc.contributor.authorSZOKE, Andrei
dc.contributor.authorRICHARD, Jean-Romain
dc.contributor.authorFOND, Guillaume
hal.structure.identifierInstitut de Neurosciences cognitives et intégratives d'Aquitaine [INCIA]
dc.contributor.authorMISDRAHI, David
dc.contributor.authorLAJNEF, Mohamed
hal.structure.identifierNutrition et Neurobiologie intégrée [NutriNeuro]
dc.contributor.authorAOUIZERATE, Bruno
IDREF: 069471851
dc.contributor.authorBOYER, Laurent
dc.contributor.authorBERNA, Fabrice
dc.contributor.authorCAPDEVIELLE, Delphine
dc.contributor.authorANDRÉ, Myrtille
dc.contributor.authorCHEREAU, Isabelle
dc.contributor.authorCLAUSS-KOBAYASHI, Julie
dc.contributor.authorCOULON, Nathalie
dc.contributor.authorDUBERTRET, Caroline
dc.contributor.authorLEIGNIER, Sylvain
dc.contributor.authorLLORCA, Pierre Michel
dc.contributor.authorMALLET, Jasmina
dc.contributor.authorPASSERIEUX, Christine
dc.contributor.authorREY, Romain
dc.contributor.authorSCHORR, Benoit
dc.contributor.authorURBACH, Mathieu
dc.contributor.authorLEBOYER, Marion
dc.contributor.authorPIGNON, Baptiste
dc.contributor.authorSCHURHOFF, Franck
dc.date.accessioned2023-06-02T13:12:38Z
dc.date.available2023-06-02T13:12:38Z
dc.date.issued2023-05-01
dc.identifier.issn0022-3956en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/182450
dc.description.abstractEnCaffeine is the most consumed psychoactive substance worldwide. Previous studies suggested higher caffeine consumption in subjects with schizophrenia spectrum disorders (SSD) as well as associations with symptoms, medication and medication side-effects. In a large and well-characterized sample of SSD subjects we explored the association between caffeine consumption and clinical (psychosis related, severity, general health) as well as pharmacological (antipsychotic treatment, sedation potential) variables. Eight hundred four subjects with data on their caffeine (coffee and tea) consumption successively recruited were included in this study. After controlling for potential confounders (demographic variables, smoking) only the negative dimension of psychosis was associated with the amount of caffeine ingested. Less severe negative symptoms were associated with higher caffeine consumption. The effect size of this association was small (partial correlation coefficient = −0.12) but significant.
dc.language.isoENen_US
dc.subject.enCaffeine
dc.subject.enNegative dimension
dc.subject.enSchizophrenia
dc.subject.enSedation
dc.title.enClinical and pharmacological correlates of caffeine consumption in subjects with schizophrenia – Data from the FACE-SZ cohort
dc.title.alternativeJournal of Psychiatric Researchen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.jpsychires.2023.03.017en_US
dc.subject.halSciences du Vivant [q-bio]/Neurosciences [q-bio.NC]en_US
dc.identifier.pubmed36934602en_US
bordeaux.journalJournal of Psychiatric Researchen_US
bordeaux.page206-212en_US
bordeaux.volume161en_US
bordeaux.hal.laboratoriesNutriNeuro (Laboratoire de Nutrition et Neurobiologie Intégrée) - UMR 1286en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINRAEen_US
bordeaux.institutionCNRS
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.exportfalse
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Journal%20of%20Psychiatric%20Research&rft.date=2023-05-01&rft.volume=161&rft.spage=206-212&rft.epage=206-212&rft.eissn=0022-3956&rft.issn=0022-3956&rft.au=SZOKE,%20Andrei&RICHARD,%20Jean-Romain&FOND,%20Guillaume&MISDRAHI,%20David&LAJNEF,%20Mohamed&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée